Amanda Nizam, MD
Amanda Nizam, MD, is a GU medical oncologist at the Cleveland Clinic, specialized in treating bladder, kidney, and prostate cancer.
Articles by Amanda Nizam, MD
The outcomes related to sacituzumab govitecan for patients with variant histologies are highlighted.
The potential for sequencing erdafitinib and EV for patients with FGFR2/3-altered disease is considered.
The impact of squamous and other histologies on outcomes with EV are dissected.
The design of UNITE, patients sampled, and outcomes with EV after switch maintenance avelumab are explored.
Dr. Nizam provides an overview of her recent research on biomarkers of TRAEs associated with EV for aUC.
Drs. Powles and Nizam discuss her strategy of intensifying treatment upfront in oligometastatic urothelial carcinoma.
Amanda Nizam, MD, discusses her proposed trial examining EV and pembrolizumab in patients with oligometastatic UC.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.